0 items USD 0.00Search
Your search for "globaldata confo therapeutics pharmaceuticals healthcare deals alliances profile" gave back 128 results.
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
Catalog:
La Merie Publishing
May 2020
Price: USD 2,350.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
Catalog:
La Merie Publishing
June 2019
Price: USD 2,700.00
Report Package: Bispecific Antibodies This report package includes the full report T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a...
Catalog:
La Merie Publishing
July 2019
Price: USD 2,840.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
Catalog:
La Merie Publishing
May 2022
Price: USD 560.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big...
Catalog:
IQ4I
May 2021
Price: USD 7,200.00
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
“Emerging Isotopes Pipeline Analysis and Global Market – Forecast to 2029” gives comprehensive insights on the various emerging isotope based...
Catalog:
IQ4I
July 2022
Price: USD 4,950.00
“Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
Catalog:
La Merie Publishing
June 2022
Price: USD 1,170.00
